Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biopha.2020.110499 http://scihub22266oqcxt.onion/10.1016/j.biopha.2020.110499 C7334916!7334916 !32768974     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32768974 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Pharmacother 2020 ; 129 (ä): 110499 Nephropedia Template TP {{tp|p=32768974 |t=2020. Outbreak of COVID-19: An emerging global pandemic threat |pdf=|usr=}}{{32768974 }} gab.com Text Outbreak of COVID-19: An emerging global pandemic threat JO: Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32768974 #FOAvip Since the first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by the World Health Organization (WHO) as more than 200 countries and territories worldwide are affected with an increasing incidence. The SARS-CoV-2 infection results in a spectrum of non-specific signs and symptoms, ranging from asymptomatic infection, to flu-like illness such as fever, cough, dry cough and fatigue, to pneumonia, acute respiratory distress syndrome, and even multi-organ failures with high morbidity and mortality. SARS-CoV-2 is mainly transmitted through respiratory droplets that infected people exhale during incubation and onset period. By 12 June 2020, over 7.5 million confirmed cases of Coronavirus disease 2019 (COVID-19) with more than 421,000 deaths in the world have been reported to the WHO. No specific medication is approved to treat COVID-19, raising the urgent need for antiviral drug development. By 12 June 2020, there are over 1000 clinical trials registered in clinicaltrials.gov for treatment of COVID-19. This review summarizes the epidemiology, virology, clinical presentation, pathophysiology, diagnosis, and particularly the antiviral drugs currently under clinical trials for treatment of SARS-CoV-2 infection, together with the challenges and perspectives of this disease are also discussed. Twit Text FOAVip Outbreak of COVID-19: An emerging global pandemic threat ????Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32768974 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32768974 #FOAvip English Wikipedia <ref>{{Cite pmid|32768974 }}</ref> Outbreak of COVID-19: An emerging global pandemic threat #MMPMID32768974 Peng M Biomed Pharmacother 2020[Sep]; 129 (ä): 110499 PMID32768974 show ga Since the first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by the World Health Organization (WHO) as more than 200 countries and territories worldwide are affected with an increasing incidence. The SARS-CoV-2 infection results in a spectrum of non-specific signs and symptoms, ranging from asymptomatic infection, to flu-like illness such as fever, cough, dry cough and fatigue, to pneumonia, acute respiratory distress syndrome, and even multi-organ failures with high morbidity and mortality. SARS-CoV-2 is mainly transmitted through respiratory droplets that infected people exhale during incubation and onset period. By 12 June 2020, over 7.5 million confirmed cases of Coronavirus disease 2019 (COVID-19) with more than 421,000 deaths in the world have been reported to the WHO. No specific medication is approved to treat COVID-19, raising the urgent need for antiviral drug development. By 12 June 2020, there are over 1000 clinical trials registered in clinicaltrials.gov for treatment of COVID-19. This review summarizes the epidemiology, virology, clinical presentation, pathophysiology, diagnosis, and particularly the antiviral drugs currently under clinical trials for treatment of SARS-CoV-2 infection, together with the challenges and perspectives of this disease are also discussed. |*Clinical Laboratory Techniques [MESH] |Antiviral Agents/administration & dosage [MESH] |Betacoronavirus/isolation & purification [MESH] |COVID-19 [MESH] |COVID-19 Drug Treatment [MESH] |COVID-19 Testing [MESH] |Coronavirus Infections/diagnosis/drug therapy/*epidemiology [MESH] |Disease Outbreaks [MESH] |Humans [MESH] |Pandemics [MESH] |Pneumonia, Viral/diagnosis/drug therapy/*epidemiology [MESH]Outbreak of COVID-19: An emerging global pandemic threat (epmc).pdf DeepDyve Pubget Overpricing